
pmid: 7997708
AbstractA primary endpoint of AIDS trials is the length of survival. Often there is auxiliary information available on measures of disease progression, which significantly alter the risk of mortality. This paper explores the use of this information in obtaining a refined estimate of survival, and a test based on this estimate. The methods are applied to an AIDS clinical trial, and results of simulations are provided which compare the approach to standard methods for survival analysis.
Acquired Immunodeficiency Syndrome, Clinical Trials as Topic, Models, Statistical, Time Factors, Survival Analysis, Statistics, Nonparametric, Treatment Outcome, Data Interpretation, Statistical, Humans, Proportional Hazards Models
Acquired Immunodeficiency Syndrome, Clinical Trials as Topic, Models, Statistical, Time Factors, Survival Analysis, Statistics, Nonparametric, Treatment Outcome, Data Interpretation, Statistical, Humans, Proportional Hazards Models
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 48 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
